• LAST PRICE
    13.6300
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    13.0800/ 1
  • Ask / Lots
    15.8900/ 1
  • Open / Previous Close
    0.0000 / 13.6300
  • Day Range
    ---
  • 52 Week Range
    Low 3.7950
    High 18.1500
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 13.33
TimeVolumeNPCE
09:32 ET12813.36
10:35 ET17913.34
10:37 ET10013.24
10:39 ET70013.2512
10:42 ET10013.285
10:44 ET30013.28
10:48 ET10013.27
10:51 ET56413.38
11:06 ET50013.52
11:08 ET20013.47
11:09 ET10013.57
11:13 ET10013.58
11:15 ET20013.68
11:31 ET62513.53
11:33 ET59713.58
11:38 ET29513.58
11:56 ET199213.87
11:58 ET11713.825
12:03 ET20014.05
12:05 ET44813.95
12:16 ET10014.095
12:20 ET200814.05
12:32 ET34014.12
12:34 ET10014.12
12:36 ET10014.125
12:38 ET190013.92
12:39 ET60013.92
12:50 ET10013.98
12:52 ET329814
12:59 ET10114.05
01:01 ET10014.05
01:10 ET30013.96
01:12 ET30014
01:24 ET10013.99
01:28 ET10014.05
01:39 ET60013.92
02:02 ET30013.905
02:04 ET80013.955
02:08 ET37313.94
02:13 ET30014.01
02:18 ET103314.045
02:31 ET21014.11
02:36 ET30014
02:42 ET125313.91
02:44 ET136413.86
02:45 ET23013.88
02:47 ET21113.89
02:54 ET40013.905
03:00 ET60113.86
03:20 ET20013.7
03:21 ET30013.61
03:27 ET670913.58
03:30 ET46213.57
03:32 ET20013.67
03:38 ET10013.63
03:43 ET10013.74
03:45 ET20013.66
03:50 ET20013.56
03:54 ET13313.595
03:57 ET30013.56
03:59 ET74713.63
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesNPCE
Neuropace Inc
386.3M
-10.6x
---
United StatesEDAP
Edap Tms SA
262.1M
-11.4x
---
United StatesBFLY
Butterfly Network Inc
220.6M
-1.6x
---
United StatesMXCT
MaxCyte Inc
449.8M
-11.9x
---
United StatesMASS
908 Devices Inc.
228.7M
-6.1x
---
United StatesSTIM
Neuronetics Inc
142.8M
-4.5x
---
As of 2024-03-28

Company Information

NeuroPace, Inc. is a medical device company. The Company is focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is a brain-responsive platform that delivers personalized, real-time treatment at the seizure source. The Company has developed its RNS System to address the individualized nature of drug-resistant epilepsy and deliver a safe therapy for focal onset seizures anywhere in the brain. The RNS System is a device that records brain activity data and allows clinicians to monitor patients not only in person, but also remotely. RNS System monitors and analyzes the brain’s electrical activity, recognizes patient-specific abnormal patterns, and delivers treatment at the seizure source. The Company’s RNS System is also engaged in treating other brain disorders, including depression, impulse control disorders, memory disorders, and post-traumatic stress disorder.

Contact Information

Headquarters
455 N. Bernardo AvenueMOUNTAIN VIEW, CA, United States 94043
Phone
650-237-2700
Fax
650-237-2701

Executives

Chairman of the Board
Frank Fischer
President, Chief Executive Officer, Director
Joel Becker
Chief Financial Officer and Vice President, Finance and Administration
Rebecca Kuhn
Chief Medical Officer
Martha Morrell
Independent Director
Lisa Andrade

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$386.3M
Revenue (TTM)
$65.4M
Shares Outstanding
28.3M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-1.28
Book Value
$0.74
P/E Ratio
-10.6x
Price/Sales (TTM)
5.9
Price/Cash Flow (TTM)
---
Operating Margin
-41.54%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.